Yihua Health Medical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
The Company held the 2022 Annual General Meeting on May 19, 2023, where 3 non-independent directors and 2 independent directors were elected to form the ninth Board of Directors. Additionally, 2 non-employee representative supervisors were elected, along with 1 employee representative supervisor elected at the employee representative meeting held on May 12, 2023, to form the ninth Supervisory Board. The terms for both boards are three years from the date of election approval at the 2022 Annual General Meeting.
On May 19, 2023, the Company convened the first meeting of the ninth Board of Directors and the first meeting of the ninth Supervisory Board, where the Chairman of the Board, members of the specialized committees, and the Chairman of the Supervisory Board were elected, and senior management was appointed. The elections for the Board of Directors and Supervisory Board have been completed, and the relevant information is announced as follows:
Composition of the Ninth Board of Directors
The ninth Board of Directors consists of 5 directors, including 3 non-independent directors and 2 independent directors. The specific members are as follows:
| Position | Name |
|---|---|
| Chairman | Mr. Lin Xiangdong |
| Non-independent Director | Ms. Wang Boyan |
| Non-independent Director | Mr. Chen Ziyan |
| Independent Director | Mr. Yu Zhugen (Accounting Professional) |
| Independent Director | Mr. Liu Jun |
The term of the ninth Board of Directors is three years from the date of election approval at the 2022 Annual General Meeting. The above board members (resumes attached) meet the qualifications for directors of listed companies as stipulated by relevant laws, regulations, and normative documents. There are no circumstances that disqualify them from serving as directors under the Company Law, the Shenzhen Stock Exchange Listing Rules, and the Company’s Articles of Association. None of them have been identified as market entry bans by the China Securities Regulatory Commission (CSRC) that have not been lifted, nor have they been penalized by the CSRC or other relevant departments, and they are not listed as dishonest executors.
The number of directors who also serve as senior management does not exceed half of the total number of directors, and the proportion of independent directors is not less than one-third of the total board members, in compliance with relevant laws, regulations, and the Company’s Articles of Association. According to Article 8 of the Company’s Articles of Association, "the Chairman is the legal representative of the Company," thus the legal representative of the Company will be changed to Mr. Lin Xiangdong. The Board of Directors has authorized relevant departments of the Company to handle the business registration procedures for the change of legal representative.
Composition of the Specialized Committees of the Ninth Board of Directors
The ninth Board of Directors has established four specialized committees: the Audit Committee, the Remuneration and Assessment Committee, the Nomination Committee, and the Strategy Committee, with terms from the date of approval by the Board of Directors until the expiration of the ninth Board of Directors. The members of each specialized committee are as follows: